Work

Chemotherapy with erlotinib or chemotherapy alone in advanced NSCLC with acquired resistance to EGFR tyrosine kinase inhibitors (TKI).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.7524

Authors: Sarah B. Goldberg, Geoffrey R. Oxnard, Subba Digumarthy, Alona Muzikansky, David Michael Jackman, Inga Tolin Lennes, Lecia V. Sequist

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595594956

Cites:

Cited by: 20

Related to: 10